PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,497,155 | -54.3% | 379,168 | -17.1% | 0.00% | -50.0% |
| Q2 2023 | $18,597,944 | -14.0% | 457,289 | +2.4% | 0.00% | 0.0% |
| Q1 2023 | $21,621,873 | +49.1% | 446,364 | +17.5% | 0.00% | 0.0% |
| Q4 2022 | $14,505,364 | -14.9% | 380,020 | +11.9% | 0.00% | 0.0% |
| Q3 2022 | $17,045,000 | +19.1% | 339,563 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $14,311,000 | +34.2% | 357,277 | +25.0% | 0.00% | +100.0% |
| Q1 2022 | $10,665,000 | -89.8% | 285,795 | -89.2% | 0.00% | -90.0% |
| Q4 2021 | $104,917,000 | +899.8% | 2,634,143 | +834.0% | 0.01% | +900.0% |
| Q3 2021 | $10,494,000 | -13.7% | 282,037 | -1.9% | 0.00% | 0.0% |
| Q2 2021 | $12,158,000 | -29.2% | 287,643 | -20.7% | 0.00% | -50.0% |
| Q1 2021 | $17,173,000 | -16.8% | 362,710 | +7.2% | 0.00% | -33.3% |
| Q4 2020 | $20,648,000 | +10.7% | 338,329 | -15.2% | 0.00% | 0.0% |
| Q3 2020 | $18,644,000 | +36.5% | 398,786 | +48.2% | 0.00% | +50.0% |
| Q2 2020 | $13,656,000 | +29.6% | 269,131 | +13.9% | 0.00% | 0.0% |
| Q1 2020 | $10,539,000 | -2.6% | 236,230 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $10,817,000 | +19.1% | 225,222 | -16.1% | 0.00% | +100.0% |
| Q3 2019 | $9,081,000 | -44.9% | 268,504 | -26.6% | 0.00% | -50.0% |
| Q2 2019 | $16,467,000 | +58.8% | 365,931 | +32.8% | 0.00% | 0.0% |
| Q1 2019 | $10,371,000 | +62.5% | 275,545 | +48.2% | 0.00% | +100.0% |
| Q4 2018 | $6,381,000 | -22.0% | 185,932 | +6.8% | 0.00% | 0.0% |
| Q3 2018 | $8,181,000 | +4.2% | 174,054 | -25.2% | 0.00% | 0.0% |
| Q2 2018 | $7,851,000 | +46.7% | 232,768 | +17.7% | 0.00% | 0.0% |
| Q1 2018 | $5,351,000 | -64.9% | 197,751 | -78.4% | 0.00% | -66.7% |
| Q4 2017 | $15,251,000 | +95.9% | 914,326 | +135.0% | 0.00% | +200.0% |
| Q3 2017 | $7,786,000 | -7.5% | 389,134 | -15.3% | 0.00% | -50.0% |
| Q2 2017 | $8,418,000 | +61.5% | 459,233 | -13.3% | 0.00% | +100.0% |
| Q1 2017 | $5,213,000 | -20.1% | 529,722 | -11.4% | 0.00% | 0.0% |
| Q4 2016 | $6,522,000 | -11.5% | 597,823 | +13.7% | 0.00% | -50.0% |
| Q3 2016 | $7,368,000 | +108.6% | 525,940 | +4.5% | 0.00% | +100.0% |
| Q2 2016 | $3,532,000 | +73.1% | 503,119 | +58.7% | 0.00% | – |
| Q1 2016 | $2,041,000 | -91.5% | 316,994 | -57.1% | 0.00% | -100.0% |
| Q4 2015 | $23,966,000 | +45.8% | 739,687 | +20.1% | 0.01% | +50.0% |
| Q3 2015 | $16,442,000 | +209.4% | 615,790 | +457.8% | 0.00% | +100.0% |
| Q2 2015 | $5,314,000 | +134.0% | 110,400 | +195.7% | 0.00% | +100.0% |
| Q1 2015 | $2,271,000 | +415.0% | 37,335 | +338.2% | 0.00% | – |
| Q4 2014 | $441,000 | +59.2% | 8,520 | +35.4% | 0.00% | – |
| Q3 2014 | $277,000 | +6.9% | 6,293 | -36.6% | 0.00% | – |
| Q2 2014 | $259,000 | +25800.0% | 9,927 | +45022.7% | 0.00% | – |
| Q1 2014 | $1,000 | -96.7% | 22 | -98.7% | 0.00% | – |
| Q4 2013 | $30,000 | – | 1,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |